Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.1050 (-0.2%) ($4.8250 - $5.2890) on Mon. Nov. 30, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.19% (three month average) | RSI | 80 | Latest Price | $5.1050(-0.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 3.4% a day on average for past five trading days. | Weekly Trend | BCRX advances 7.6% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) SPLV(6%) VIXM(6%) EWG(4%) GDX(4%) XME(4%) | Factors Impacting BCRX price | BCRX will decline at least -2.095% in a week (0% probabilities). XHB(-8%) XBI(-8%) IBUY(-8%) ARKK(-8%) XRT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -2.095% (StdDev 4.19%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $4.81(6.13%) | 10 Day Moving Average | $4.6(10.98%) | 20 Day Moving Average | $4.37(16.82%) | To recent high | -0.2% | To recent low | 0% | Market Cap | $901m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |